BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 31908734)

  • 1. Sortilin as a Novel Diagnostic and Therapeutic Biomarker in Chronic Lymphocytic Leukemia.
    Farahi L; Ghaemimanesh F; Milani S; Razavi SM; Akhondi MM; Rabbani H
    Avicenna J Med Biotechnol; 2019; 11(4):270-276. PubMed ID: 31908734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anchored Fibromodulin as a Novel Target in Chronic Lymphocytic Leukemia: Diagnostic and Therapeutic Implications.
    Farahi L; Ghaemimanesh F; Milani S; Razavi SM; Hadavi R; Bayat AA; Salimi A; Akhondi MM; Rabbani H
    Iran J Immunol; 2019 Jun; 16(2):127-141. PubMed ID: 31182687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. KLKB1 mRNA overexpression: A novel molecular biomarker for the diagnosis of chronic lymphocytic leukemia.
    Adamopoulos PG; Kontos CK; Papageorgiou SG; Pappa V; Scorilas A
    Clin Biochem; 2015 Sep; 48(13-14):849-54. PubMed ID: 25891023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic and Therapeutic Implications of Sortilin Expressed on the Surface of Bladder Carcinoma Cells.
    Bayat AA; Sadeghi N; Fazli G; Nowroozi MR; Ohadian Moghadam S; Radmanesh A; Hedayatshodeh M; Sarrafzadeh AR; Zarei O; Ghaemimanesh F; Rabbani H
    Iran J Pathol; 2022; 17(2):174-182. PubMed ID: 35463727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. mRNA overexpression of kallikrein-related peptidase 14 (KLK14) is an independent predictor of poor overall survival in chronic lymphocytic leukemia patients.
    Kontos CK; Adamopoulos PG; Papageorgiou SG; Pappa V; Scorilas A
    Clin Chem Lab Med; 2016 Feb; 54(2):315-24. PubMed ID: 26351937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting lipid metabolism by the lipoprotein lipase inhibitor orlistat results in apoptosis of B-cell chronic lymphocytic leukemia cells.
    Pallasch CP; Schwamb J; Königs S; Schulz A; Debey S; Kofler D; Schultze JL; Hallek M; Ultsch A; Wendtner CM
    Leukemia; 2008 Mar; 22(3):585-92. PubMed ID: 18079738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rituximab: a review of its use in non-Hodgkin's lymphoma and chronic lymphocytic leukaemia.
    Plosker GL; Figgitt DP
    Drugs; 2003; 63(8):803-43. PubMed ID: 12662126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LAG-3 Blockade with Relatlimab (BMS-986016) Restores Anti-Leukemic Responses in Chronic Lymphocytic Leukemia.
    Sordo-Bahamonde C; Lorenzo-Herrero S; González-Rodríguez AP; Payer ÁR; González-García E; López-Soto A; Gonzalez S
    Cancers (Basel); 2021 Apr; 13(9):. PubMed ID: 33925565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurotensin receptor type 2 protects B-cell chronic lymphocytic leukemia cells from apoptosis.
    Abbaci A; Talbot H; Saada S; Gachard N; Abraham J; Jaccard A; Bordessoule D; Fauchais AL; Naves T; Jauberteau MO
    Oncogene; 2018 Feb; 37(6):756-767. PubMed ID: 29059151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relation of Neutrophil Gelatinase-Associated Lipocalin Overexpression to the Resistance to Apoptosis of Tumor B Cells in Chronic Lymphocytic Leukemia.
    Bauvois B; Pramil E; Jondreville L; Chapiro E; Quiney C; Maloum K; Susin SA; Nguyen-Khac F
    Cancers (Basel); 2020 Jul; 12(8):. PubMed ID: 32751884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel, mitochondrial, internal tRNA-derived RNA fragment possesses clinical utility as a molecular prognostic biomarker in chronic lymphocytic leukemia.
    Karousi P; Adamopoulos PG; Papageorgiou SG; Pappa V; Scorilas A; Kontos CK
    Clin Biochem; 2020 Nov; 85():20-26. PubMed ID: 32745483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting the CXCR4 pathway using a novel anti-CXCR4 IgG1 antibody (PF-06747143) in chronic lymphocytic leukemia.
    Kashyap MK; Amaya-Chanaga CI; Kumar D; Simmons B; Huser N; Gu Y; Hallin M; Lindquist K; Yafawi R; Choi MY; Amine AA; Rassenti LZ; Zhang C; Liu SH; Smeal T; Fantin VR; Kipps TJ; Pernasetti F; Castro JE
    J Hematol Oncol; 2017 May; 10(1):112. PubMed ID: 28526063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chrysin induces apoptosis in peripheral blood lymphocytes isolated from human chronic lymphocytic leukemia.
    Zaric M; Mitrovic M; Nikolic I; Baskic D; Popovic S; Djurdjevic P; Milosavljevic Z; Zelen I
    Anticancer Agents Med Chem; 2015; 15(2):189-95. PubMed ID: 25257897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression and function of the FAS antigen in B chronic lymphocytic leukemia and hairy cell leukemia.
    Panayiotidis P; Ganeshaguru K; Foroni L; Hoffbrand AV
    Leukemia; 1995 Jul; 9(7):1227-32. PubMed ID: 7543175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection and characterization of human high molecular weight B cell growth factor receptors on leukemic B cells in chronic lymphocytic leukemia.
    Uckun FM; Fauci AS; Chandan-Langlie M; Myers DE; Ambrus JL
    J Clin Invest; 1989 Nov; 84(5):1595-608. PubMed ID: 2681271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monoclonal Antibody Against Sortilin Induces Apoptosis in Human Breast Cancer Cells.
    Simonian M; Haji Ghaffari M; Salimi A; Mirzadegan E; Sadeghi N; Ebrahimnezhad N; Fazli G; Fatemi R; Bayat AA; Milani S; Negahdari B; Rabbani H
    Avicenna J Med Biotechnol; 2022; 14(1):37-45. PubMed ID: 35509360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of a novel, internal tRNA-derived RNA fragment as a new prognostic and screening biomarker in chronic lymphocytic leukemia, using an innovative quantitative real-time PCR assay.
    Katsaraki K; Artemaki PI; Papageorgiou SG; Pappa V; Scorilas A; Kontos CK
    Leuk Res; 2019 Dec; 87():106234. PubMed ID: 31669784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD62L as a therapeutic target in chronic lymphocytic leukemia.
    Burgess M; Gill D; Singhania R; Cheung C; Chambers L; Renyolds BA; Smith L; Mollee P; Saunders N; McMillan NA
    Clin Cancer Res; 2013 Oct; 19(20):5675-85. PubMed ID: 23948971
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antigen modulation followed by quantitative flow cytometry of B-chronic lymphocytic leukemia cells after treatment.
    Kusenda J; Babusíková O
    Neoplasma; 2004; 51(2):97-102. PubMed ID: 15190418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnosis and prognosis of B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma (B-CLL/SLL) and mantle cell lymphoma (MCL).
    Asaad NY; Abd El-Wahed MM; Dawoud MM
    J Egypt Natl Canc Inst; 2005 Dec; 17(4):279-90. PubMed ID: 17102815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.